Efficacy of pharmacological treatment and genetic characterization in early diagnosed patients affected by long QT syndrome with impaired AV conduction

International Journal of Cardiology

Volumn 149, Issue 1, 2011, Pages 109-113

  Sarubbi, B ^a   Frisso, G ^b,c,d   Romeo, E ^a   Evangelista, E ^c   Cordella, A ^b,c,d   D'Alto, M ^a   Santarpia, G ^a   Russo, M G ^a   Salvatore, F ^b,d   Calabro R ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b CEINGE Biotecnologie Avanzate Scarl Napoli   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d IRCCS SDN   (Italy)

Author keywords

AV block; Genetic analysis; Long QT syndrome; Mexiletine; Sudden death; Torsade de pointes; blockers

Indexed keywords

ANTIARRHYTHMIC AGENT; GLUCOSE; MEXILETINE; PROPRANOLOL;

ANAMNESIS; ATRIOVENTRICULAR CONDUCTION; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONGENITAL HEART MALFORMATION; DRUG EFFICACY; DRUG MECHANISM; EARLY DIAGNOSIS; ELECTROCARDIOGRAM; FEMALE; GENETIC TRAIT; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOGLYCEMIA; LETTER; LONG QT SYNDROME; MALE; MORTALITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SYSTEMIC DISEASE; TORSADE DES POINTES;

EID: 79955941431     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.12.099     Document Type: Article

References (21)

1. Trippel DL, Parsons MK, Gillette PC. Infants with long-QT syndrome and 2:1 atrioventricular block. Am Heart J 1995;130:1130-4.
2. Gorgels APM, Al Fadley F, Zaman L, et al. The long QT syndrome with impaired atrioventricular conduction: a malignant variant in infants. J Cardiovasc Electrophysiol 1998;9:1225-32. (Pubitemid 28516152)
3. Garson Jr A, Dick M, Fournier A, et al. The long QT syndrome in children. An international study of 287 patients. Circulation 1993;87:1866-72.
4. Saoudi N, Bozio A, Kirkorian G, et al. Prolonged QT, atrioventricular block, and sudden death in the newborn: an electrophysiologic evaluation. Eu Heart J 1991;12:838-41.
5. Van Hare GF, Franz MR, Roge C, et al. Persistent functional atrioventricular block in two patients with prolonged QT intervals: elucidation of the mechanism of the block. Pacing Clin Electrophysiol 1990;13:608-18. (Pubitemid 20202930)
6. Bharati S, Dreifus L, Bucheleres G, et al. The conduction system in patients with a prolonged QT interval. J Am Coll Cardiol 1985;6:1110-9. (Pubitemid 16219210)
7. Patel C, Narayanaswamy S, Medina-Ravell VA, et al. A rare case of 2:1 AV block: long QT syndrome. J Cardiovasc Electrophysiol 2008;19:1990.
8. Aziz PF, Tanel RE, Zelster IJ, et al. Congenital long QT syndrome and 2:1 atrioventricular block: an optimistic outcome in the current era. Heart Rhythm 2010. Heart Rhythm 2010;7:781-5.
9. Balaji S. Long QT syndrome in children: not one disease anymore. J Am Coll Cardiol 2007;50:1341-2.
10. Rosenbaum MB, Acunzo RS. Pseudo 2:1 atrioventricular block and T wave alternans in the long QT syndromes. J Am Coll Cardiol 1991;18:1363-6.
11. Spazzolini C, Mullally J, Moss AJ, et al. Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy. J Am Coll Cardiol 2009;25(54):832-7.
12. Shimlizul W, Aiba T, Antzelevitch C. Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. long QT syndrome and Brugada syndrome. Curr Pharm Des 2005;11:1561-72. (Pubitemid 40691452)
13. Lupoglazoff JM, Denjoy I, Villain E, et al. Long QT syndrome in neonates. Conduction disorders associated with HERG mutations and sinus bradycardia with KCNQ1 mutations. J Am Coll Cardiol 2004;43:826-30. (Pubitemid 38296483)
14. Piippo K, Laitinen P, Swan H, et al. Homozygosity for a HERG potassium channel mutation causes a severe form of long QT syndrome: identification of an apparent founder mutation in the Finns. J Am Coll Cardiol 2000;35:1919-25. (Pubitemid 30342876)
15. Lupoglazoff JM, Cheav T, Baroudi G, et al. Homozygous SCN5A mutation in long QT syndrome with functional two-to-one atrioventricular block. Circ Res 2001;89:e16-21.
16. Chang CC, Acharfi S, Wu MH, et al. A novel SCN5A mutation manifests as a malignant form of long Qt syndrome with perinatal onset of tachycardia/ bradycardia. Cardiovasc Res 2004;64:268-78. (Pubitemid 39361688)
17. Medeiros-Domingo A, Kaku T, Tester DJ, et al. SCN4B-Encoded sodium channel beta4 subunit in congenital long-QT syndrome. Circulation 2007;116:134-42. (Pubitemid 47057518)
18. Splawski I, Timothy KW, Sharpe LM, et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004;119:19-31.
19. Yang Y, Liu Y, Dong X, et al. Human KCNQ1 S140G mutation is associated with atrioventricular blocks. Heart Rhythm 2007;4:611-8. (Pubitemid 46630381)
20. Frisso G, Limongelli G, Pacileo G, et al. A child cohort study from southern Italy enlarges the genetic spectrum of hypertrophic cardiomyopathy. Clin Genet 2009;76:91-101.
21. Shewan LG, Coats AJ. Ethics in the authorship and publishing of scientific articles. Int J Cardiol 2010;144:1-2.